Copperwynd Financial, LLC Bristol Myers Squibb CO Transaction History

Copperwynd Financial, LLC

  • $318 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
BUY
$68.48 - $81.09 $12,326 - $14,596
180 Added 1.01%
17,914 $1.29 Million
Q3 2022

Nov 10, 2022
SELL
$0.13 - $76.84 $3,579 - $2.12 Million
-27,535 Reduced 60.83%
17,734 $1.26 Million
Q2 2022

Aug 05, 2022
BUY
$72.62 - $79.98 $3.29 Million - $3.62 Million
45,269 New
45,269 $3.49 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email